Loading company financials…
NASDAQ NMS - GLOBAL MARKET · Consumer products · CIK 0000822663
$116.07
+2.54% · live
Updated
$3.72B market value
From INTERPARFUMS INC's FY2025 10-K, filed Mar 10, 2026 · read the filing
INTERPARFUMS makes soap, cleaning and personal care products. It took in $1.49B last year, which makes it a mid-sized company. Of every dollar it sells, about 11 cents is left as profit.
The financial picture is led by profitability, debt and accounting, with growth worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by Gabai-Pinsky Veronique, not under a pre-arranged plan.
$105.2K sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Strong finances across the board.
From INTERPARFUMS INC's FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Capital spending
$4.7M → $24.4M
Dividends paid
$96.0M → $102.7M
4 of 4 scored areas had enough reported figures to judge
Measured against FY2024, from the 10-K filed Mar 10, 2026
Changed: +415.1%
$4.7M to $24.4MCritical
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Changed: +7.0%
$96.0M to $102.7MNotable
Why it matters: Cash handed to shareholders. A rise can be a higher dividend or simply more shares, and a cut is a decision the company explains in its own filing — neither is rated here.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 4, 2026.
How the latest move compares (quote live), and what was published around it
IPAR rose 2.54% on the latest quote. The average Consumer Staples company tracked here moved +4.05%, and the S&P 500 −1.04%. That is 1.5 points below its sector and 3.6 points above the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 6% a year for the next 10 years. Over the last 10 years it grew by about 15% a year.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 11 cents of every dollar of sales as profit, earning $168.4M last year.
Barely. Sales were roughly flat, up 2.5%.
No. Its borrowings would take under a year of cash flow to clear. For every $1 it owes, it owns $2.25 in assets.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 61 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It paid out 48% of the cash its operations generated. It has paid in each of the last 12 years.
GoodNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2025 annual filing
Last year it earned $168.4M and generated $214.9M of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Mar 10, 2026Filing for FY2025 | FY202410-K · Mar 10, 2026Filing for FY2024 | FY202310-K · Feb 27, 2024Filing for FY2023 | FY202210-K · Feb 27, 2024Filing for FY2022 | FY202110-K · Feb 27, 2024Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $1.49B | $1.45B | $1.32B | $1.09B | $879.5M | +2.5% |
| Cost of revenue | $541.3M | $525.0M | $478.6M | $392.2M | $322.6M | +3.1% |
| Gross profit | $947.2M | $927.3M | $839.1M | $694.4M | $556.9M | +2.1% |
| Gross marginGross profit ÷ revenueWhat is this? | 63.6% | 63.9% | 63.7% | 63.9% | 63.3% | −0.2 pts |
| Selling, general and administrative | $676.9M | $648.5M | $587.7M | $492.4M | $406.5M | +4.4% |
| Operating income | $270.3M | $274.8M | $251.4M | $194.3M | $148.1M | −1.6% |
| Operating marginOperating income ÷ revenueWhat is this? | 18.2% | 18.9% | 19.1% | 17.9% | 16.8% | −0.8 pts |
| Interest expense | $7.2M | $7.8M | $11.3M | $3.6M | $2.8M | −7.4% |
| Income before tax | $271.3M | $268.4M | $249.6M | $194.2M | $151.0M | +1.1% |
| Net income | $168.4M | $164.4M | $152.7M | $120.9M | $87.4M | +2.5% |
| Net marginNet income ÷ revenueWhat is this? | 11.3% | 11.3% | 11.6% | 11.1% | 9.9% | −0.0 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $5.25 | $5.12 | $4.77 | $3.78 | $2.75 | +2.6% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| IPARINTERPARFUMS INC · this page | 9.0/10 | 7/9 | 2.5% |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Exercised stock options — 900 shares at $97.84 ($88.1K)
Holds 900 shares after this filing.
Sold on the open market — 900 shares at $116.86 ($105.2K)
Holds 0 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Published results · Made a Regulation FD disclosure
Read the filingReported another event
Read the filingWrite down why you are following INTERPARFUMS INC, what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 11 subsidiaries named in its 10-K, incorporated across 10 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from IPAR's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Mar 10, 2026), reported under the US GAAP taxonomy. View the source filing. Total liabilities were not tagged directly and were calculated as assets minus equity.
The score averages profitability, growth, debt and accounting. All four had enough reported figures. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 9 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 9.0 | 7/9 | 10-K, filed Mar 10, 2026 |
| FY2024 | 9.0 | 9/9 | 10-K, filed Mar 11, 2025 |
| FY2023 | 9.0 | 7/9 | 10-K, filed Feb 27, 2024 |
| FY2022 | 10.0 | 7/9 | 10-K, filed Feb 28, 2023 |
| FY2021 | 7.0 | 6/9 | 10-K, filed Mar 1, 2022 |
| FY2020 | 8.0 | 7/9 | 10-K, filed Mar 1, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
7 of 9 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's.
5.92
In the safe zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
-2.41
Below the threshold — nothing unusual flagged
Scores above -1.78 are the ones the model associates with earnings manipulation.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Deteriorated: -17.3%
$59.2M to $48.9MSignificant
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: −3.4 pts
17.7% to 14.4%Significant
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: -37.0%
$153.1M to $96.5MSignificant
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 4, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Deteriorated: -34.0%
$74.1M to $48.9MSignificant
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: -29.7%
$43.4M to $30.5MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −7.1 pts
21.5% to 14.4%Significant
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −3.6 pts
12.6% to 8.9%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -29.7%
$1.35 to $0.95Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: -10.0%
$107.2M to $96.5MNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
11 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 4% and 8%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Opinions from 13 analysts covering this company, as of . Their views, not this site's.
Of 13 analysts publishing on this company, 3 say strong buy, 5 say buy, 4 say hold and 1 say sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 6.4% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 21.7x — investors pay $21.7 for each $1 of trailing profit.
Nothing unusual. Its accounting patterns look like those of companies that report earnings straightforwardly.
| 11.3% |
| 22.10x |
| 0.80x |
| ELESTEE LAUDER COMPANIES INC | 7.0/10 | 8/9 | 5.0% | 1.2% | 214.43x | 4.19x |
|---|
| COTYCOTY INC. | 4.0/10 | 5/9 | -1.5% | -10.4% | — | 2.28x |
|---|
| Median of peers | 5.5/10 | — | 1.8% | -4.6% | 214.43x | 3.24x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Filed notice to sell 900 shares ($105.2K) on or after .
Shares originally obtained via stock options.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Reported another event
Held a shareholder vote · Reported another event
Read the filingPublished results · Made a Regulation FD disclosure · Reported another event
Read the filingQuarterly report for Q2 FY2026
Operating margin −3.4 pts · Operating income -17.3% · Long-term debt -37.0% — against Q2 FY2025
Read the filingProxy statement for a shareholder meeting
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingChanged its auditor
Read the filingPublished results · Made a Regulation FD disclosure · Reported another event
Read the filingQuarterly report for Q1 FY2026
Free cash flow $7.5M narrower · Gross margin +1.4 pts · Capital spending -5.3% — against Q1 FY2025
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingAnnual report for FY2025
Capital spending +415.1% · Dividends paid +7.0% — against FY2024
Read the filingPublished results · Made a Regulation FD disclosure · Reported another event
Read the filingMade a Regulation FD disclosure · Reported another event
Read the filingMade a Regulation FD disclosure · Reported another event
Read the filingReported another event
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingMade a Regulation FD disclosure
Read the filingPublished results · Made a Regulation FD disclosure · Reported another event
Read the filingSource: Exhibit 21 of the 10-K filed 2026-03-10. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
IPAR's Q3 Sales Flat at $430M as Europe Growth Offsets US Decline
Yahoo Finance ·
Interparfums Q3 sales flat at $430 million as U.S. giftset shipments delayed
Yahoo Finance ·
Interparfums, Inc. Reports 2026 Third Quarter Net Sales
Yahoo Finance ·
Is Interparfums (ENXTPA:ITP) Above Fair Value on Cash Flow?
Yahoo Finance ·
1 Profitable Stock to Keep an Eye On and 2 We Ignore
Yahoo Finance ·
Is Interparfums’ (IPAR) New Global Fragrance Deal a Game-Changer?
Yahoo Finance ·
Interparfums’ Long-Term Puma and Cavalli Fragrance Deals Could Be A Game Changer For IPAR
Yahoo Finance ·
Interparfums (IPAR) Could Be 7% Undervalued After PUMA And Cavalli License Deals
Yahoo Finance ·
Interparfums (IPAR) Extends Cavalli Fragrance Deal Through 2046. Can it Boost Profits?
Yahoo Finance ·
Interparfums Inks Global Fragrance Deal With Puma, Launch Set for 2027
Yahoo Finance ·
Interparfums, Inc. Announces Exclusive Worldwide License Agreement With PUMA
Yahoo Finance ·
3 Reasons to Avoid IPAR and 1 Stock to Buy Instead
Yahoo Finance ·
Primary sources and further research